Gregory E Miller1, Edith Chen1, Madeleine U Shalowitz2, Rachel E Story2, Adam K K Leigh1, Paula Ham1, Jesusa M G Arevalo3, Steve W Cole3. 1. Department of Psychology and Institute for Policy Research, Northwestern University, Evanston, Illinois. 2. NorthShore University Health Systems, University of Chicago, Pritzker School of Medicine, Chicago, Illinois. 3. Division of Hematology-Oncology, UCLA AIDS Institute, Molecular Biology Institute, Jonsson Comprehensive Cancer Center, and Norman Cousins Center, UCLA School of Medicine, Los Angeles, California.
Abstract
AIM: There are marked socioeconomic disparities in pediatric asthma control, but the molecular origins of these disparities are not well understood. To fill this gap, we performed genome-wide expression profiling of monocytes and T-helper cells from pediatric asthma patients of lower and higher socioeconomic status (SES). METHOD: Ninety-nine children with asthma participated in a cross-sectional assessment. Out of which 87% were atopic, and most had disease of mild (54%) or moderate (29%) severity. Children were from lower-SES (n = 49; household income <$50 000) or higher-SES (n = 50; household income >$140 000) families. Peripheral blood monocytes and T-helper cells were isolated for genome-wide expression profiling of mRNA. RESULTS: Lower-SES children had worse asthma quality of life relative to higher-SES children, by both their own and their parents' reports. Although the groups had similar disease severity and potential confounds were controlled, their transcriptional profiles differed notably. The monocytes of lower-SES children showed transcriptional indications of up-regulated anti-microbial and pro-inflammatory activity. The T-helper cells of lower-SES children also had comparatively reduced expression of genes encoding γ-interferon and tumor necrosis factor-α, cytokines that orchestrate Type 1 responses. They also showed up-regulated activity of transcription factors that polarize cells towards Type 2 responses and promote Th17 cell maturation. CONCLUSION: Collectively, these patterns implicate pro-inflammatory monocytes and Type 2 cytokine activity as mechanisms contributing to worse asthma control among lower-SES children.
AIM: There are marked socioeconomic disparities in pediatric asthma control, but the molecular origins of these disparities are not well understood. To fill this gap, we performed genome-wide expression profiling of monocytes and T-helper cells from pediatric asthmapatients of lower and higher socioeconomic status (SES). METHOD: Ninety-nine children with asthma participated in a cross-sectional assessment. Out of which 87% were atopic, and most had disease of mild (54%) or moderate (29%) severity. Children were from lower-SES (n = 49; household income <$50 000) or higher-SES (n = 50; household income >$140 000) families. Peripheral blood monocytes and T-helper cells were isolated for genome-wide expression profiling of mRNA. RESULTS: Lower-SES children had worse asthma quality of life relative to higher-SES children, by both their own and their parents' reports. Although the groups had similar disease severity and potential confounds were controlled, their transcriptional profiles differed notably. The monocytes of lower-SES children showed transcriptional indications of up-regulated anti-microbial and pro-inflammatory activity. The T-helper cells of lower-SES children also had comparatively reduced expression of genes encoding γ-interferon and tumor necrosis factor-α, cytokines that orchestrate Type 1 responses. They also showed up-regulated activity of transcription factors that polarize cells towards Type 2 responses and promote Th17 cell maturation. CONCLUSION: Collectively, these patterns implicate pro-inflammatory monocytes and Type 2 cytokine activity as mechanisms contributing to worse asthma control among lower-SES children.
Authors: Rosalind J Wright; Patricia Finn; Johanna Paola Contreras; Sheldon Cohen; Robert O Wright; John Staudenmayer; Matthew Wand; David Perkins; Scott T Weiss; Diane R Gold Journal: J Allergy Clin Immunol Date: 2004-06 Impact factor: 10.793
Authors: Edith Chen; Madeleine U Shalowitz; Rachel E Story; Katherine B Ehrlich; Cynthia S Levine; Robin Hayen; Adam K K Leigh; Gregory E Miller Journal: Psychosom Med Date: 2016 Nov/Dec Impact factor: 4.312
Authors: Ketan Shankardass; Rob McConnell; Michael Jerrett; Joel Milam; Jean Richardson; Kiros Berhane Journal: Proc Natl Acad Sci U S A Date: 2009-07-20 Impact factor: 11.205
Authors: Sheldon Cohen; Cuneyt M Alper; William J Doyle; Nancy Adler; John J Treanor; Ronald B Turner Journal: Health Psychol Date: 2008-03 Impact factor: 4.267
Authors: Sheldon Cohen; Denise Janicki-Deverts; Ronald B Turner; Anna L Marsland; Margaretha L Casselbrant; Ha-Sheng Li-Korotky; Elissa S Epel; William J Doyle Journal: Brain Behav Immun Date: 2013-07-08 Impact factor: 7.217
Authors: Cyrielle Holuka; Myriam P Merz; Sara B Fernandes; Eleftheria G Charalambous; Snehaa V Seal; Nathalie Grova; Jonathan D Turner Journal: Int J Mol Sci Date: 2020-07-19 Impact factor: 5.923
Authors: Eleftheria G Charalambous; Sophie B Mériaux; Pauline Guebels; Claude P Muller; Fleur A D Leenen; Martha M C Elwenspoek; Ines Thiele; Johannes Hertel; Jonathan D Turner Journal: Int J Mol Sci Date: 2021-11-24 Impact factor: 5.923